Simcere Pharmaceutical Group Ltd. is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Its primary focus is on the... Simcere Pharmaceutical Group Ltd. is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Its primary focus is on the creation of innovative and high-quality medications that address significant medical needs across various therapeutic areas. The company is well-regarded for its diverse product portfolio, which includes treatments for cancer, cardiovascular diseases, and autoimmune conditions. Simcere is heavily invested in R&D, collaborating with global partners to advance translational medicine and bring cutting-edge therapies to market. Its commitment to scientific excellence and patient-centric solutions positions it at the forefront of the pharmaceutical industry. Headquartered in Nanjing, China, Simcere plays an influential role not only in the Chinese healthcare market but also has a growing presence in the international arena, contributing to the global effort of improving health outcomes through innovative drug development.
Pending data availability
EU Taxonomy Data missing for Simcere Pharmaceutical Group
We haven’t collected EU Taxonomy data for Simcere Pharmaceutical Group yet, or the company
hasn’t made it publicly available.